MedPath

The Effect of Albumin Levels on Pharmacokinetics of Cefazolin in Adult Cardiac Surgery: A Prospective, Randomized, Open-label, Parallel-group Pharmacokinetic Study

Phase 4
Not yet recruiting
Conditions
heart disease
hypoalbuminemia
Registration Number
2024-518338-10-00
Lead Sponsor
Medical University Of Vienna
Brief Summary

Primary objective: The area under the concentration-time curve from 0 - 10h (AUC0-10 ) for free and total drug will be compared between the control and intervention group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised, recruitment pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

written informed consent

Planned use of cardiopulmonary bypass

Age: > 18 and < 90 years

Ejection fraction > 40%

Exclusion Criteria

Inability to give informed consent

Long standing diabetes mellitus (> 7 years) and insulin-dependent diabetes mellitus

Pregnant women

The standardized priming solution (1500ml Ringer’s Lactate, 100ml Mannit 20% and 10.000IE Heparin) is deemed inappropriate according to the treating physicians

Known allergy to penicillin/cephalosporins or cefazolin

Preoperative antibiotic therapy

Preoperative serum albumin concentration <40g/L

Emergency procedure

Preoperative renal failure

Chronic severe renal insufficiency including hemodialysis

Chronic severe liver disease

BMI > 35

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The area under the concentration-time curve from 0 - 10h (AUC0-10 ) for free + total drug will be compared between the control and intervention group.

The area under the concentration-time curve from 0 - 10h (AUC0-10 ) for free + total drug will be compared between the control and intervention group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University Of Vienna

🇦🇹

Vienna, Austria

Medical University Of Vienna
🇦🇹Vienna, Austria
Doris Hutschala-Kinstner
Site contact
+4369910117565
doris.hutschala-kinstner@meduniwien.ac.at

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.